MRI developer Fonar has announced that it has resolved its pending patent infringement litigation with Elscint. Terms of the agreement were not released.The deal adds another to the list of companies that have settled MRI patent disputes with Fonar.
MRI developer Fonar has announced that it has resolved its pending patent infringement litigation with Elscint. Terms of the agreement were not released.
The deal adds another to the list of companies that have settled MRI patent disputes with Fonar. Hitachi, Philips, Siemens, Toshiba, and Shimadzu have all reached settlements with them in recent years, while GE lost its legal battle with the firm in 1997, paying a total of $128.7 million (SCAN 7/9/97).
In other Fonar news, the Melville, NY-based company has appointed Sol Ginzburg as vice president of sales. He had recently served as director of international sales for the firm.
Fonar also announced that Pennsylvania Medical Group has acquired another of its Quad 12000 devices for an imaging center in Reading, PA. The group already employs a Quad 12000 scanner at an imaging facility in Philadelphia. Fonar valued the groups latest purchase at $1.2 million.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.